December 2, 2013 · Comments Off on Fingerprint Cancer
Where a Cancer Lives May not be as Important as What it’s Made of Imagine...
May 31, 2013 · Comments Off on Stop Signals
Researchers at University of Colorado Cancer Center are discovering how androgens drive diseases such as breast and bladder cancers.
Tightening the body’s cancer-catching net
November 30, 2012 · Comments Off on Tightening the body’s cancer-catching net
At CU Cancer Center, researchers, discover how dinosaurs, diabetes, Star Trek extras and Keith Richards combine to keep the body cancer-free.
Splitting the Cancer Arrow
June 1, 2012 · Comments Off on Splitting the Cancer Arrow
Biomarkers and the precise therapies that target them will cure cancer by degrees—and change the way drugs do business.
Phase I Clinical Trials Put Cancer Patients on the Cutting Edge
December 7, 2011 · Comments Off on Phase I Clinical Trials Put Cancer Patients on the Cutting Edge
Patients like Joel Groebner and Ellen Smith are examples of people living at the cutting...
Serendipity by Design
December 5, 2011 · Comments Off on Serendipity by Design
By Garth Sundem In the University of Colorado Cancer Center’s fight against lung cancer, what...
May 26, 2011 · Comments Off on Motherhood Mystery
Cancer Center studies reveal link between pregnancy and breast cancer Story by Michele Conklin, Photos...
Exposing Cancer’s Roadmap
March 23, 2011 · Comments Off on Exposing Cancer’s Roadmap
Aik-Choon Tan stood outside a hospital room in Baltimore five years ago feeling helpless. The 28-year-old computer scientist was devoting his career to developing complex algorithms to help ferret out the workings of cancer genes. Yet, his work meant nothing to the four-year-old girl inside who was dying of cancer.
The Melanoma Puzzle
July 1, 2010 · Comments Off on The Melanoma Puzzle
Sitting around the dinner table each night, Shannon Clark and her three children play a game they call "High-Low" when each person shares the high point and the low point of their day.
June 1, 2015 · Comments Off on Promising trial results of brigatinib show that all next-gen ALK inhibitors may not be created equal
Phase I/II clinical trial results reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results for investigational drug brigatinib against ALK+ non-small cell lung cancer (NSCLC), with 58 of 78 ALK+ patients responding to treatment, including 50 of 70 patients who had progressed after previous treatment with crizotinib, the first licensed ALK inhibitor.
First-of-its-kind Canine Health Study Enrolls 3,000th Golden Retriever
April 14, 2015 · Comments Off on First-of-its-kind Canine Health Study Enrolls 3,000th Golden Retriever
In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy
February 24, 2015 · Comments Off on In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy
University of Colorado Cancer Center Joins World’s Largest Precision Cancer Research Collaboration
February 23, 2015 · Comments Off on University of Colorado Cancer Center Joins World’s Largest Precision Cancer Research Collaboration
Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
October 15, 2014 · Comments Off on Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
Wishing everyone a safe and happy July 4th! http://t.co/UGD9xujz0y